Fish oil, dash diet partially alters lipid metabolism

Published On 2021-12-13 00:41 GMT | Update On 2021-12-15 05:44 GMT

Type 2 diabetes is associated with elevated levels of metabolic abnormalities and systemic inflammation, with an increased risk of developing cardiovascular diseases (CVDs) diseases. A recent study suggests that fish oil intervention with a dietary approach to stop hypertension (DASH) had partial alteration on lipid metabolism and inflammatory mediators. The study findings were presented at the Metabolic Institute of America (TMIOA) 2021 World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC) Meeting.

Omega-3 fatty acids contain two long-chain fats: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are found in oily fish. Recent studies demonstrated the effects of EPA and DHA on the risk of developing cardiovascular disease. To further evaluate Dr Fasail Ali and team hypothesized that altering the macronutrient composition of diets in patients with diabetes might alter metabolic and inflammatory abnormalities. They conducted a study to evaluate the changes in plasma lipid profile and identify potential inflammatory mediators following the DASH diet and the omega-3 capsules supplementation.

For more details check out the full story in link below:

Fish Oil & DASH Diet Partially Alters Lipid Metabolism, Not Glycemic Control Or Adiposity

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Fish oil, dash diet partially alters lipid metabolism

Similar News

Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings

SOUL Trial Shows 14% Reduction in Cardiovascular Events with Oral Semaglutide in Type 2 Diabetes

Modified Insulin with On-Off Switch May Prevent Sudden Hypoglycemic Episodes in Diabetics: Study Finds

Obese Women are at a Higher risk of Developing Hypertension and Cardiovascular Disease: Study Finds

Glycated haemoglobin may predict disease severity among patients with NAFLD, finds study

Chemically Induced Stem Cell Islets Functionally Cure Type 1 Diabetes in Phase 1 Clinical Trial

Adverse Pregnancy Outcomes More Likely for Those with Adolescent Prediabetes: Study Reveals

Bariatric Surgery Surpasses GLP-1 Diabetes Medication in Progression of Chronic Kidney Disease, shows Cleveland Clinic Study